Paul Derose, MD
Radiation Oncology · Richardson, TXNPI 1659573780
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,500 of the $37,195 with a category attached, or 84.7%. Novocure GmbH accounts for 60.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2023 at $25,610 and has fallen 98.7% since, to $335 in 2025. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $464.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure GmbH$23K
- Novocure Inc.$13K
- AstraZeneca$284
- Sirtex Medical Inc$117
- Medtronic$94
- AbbVie$86
- plus $660 from 21 others
Across 24 payments — averaging $4060.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure GmbH$68K
- Novocure Inc.$30K
What the payments were for
- Consulting fees$31,50085%
- Speaking & faculty fees$2,5057%
- Food & beverage$3,1909%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure GmbH | 1 | $22,500 |
| Novocure Inc. | 36 | $13,455 |
| AstraZeneca | 5 | $284 |
| Sirtex Medical Inc | 1 | $117 |
| Medtronic | 2 | $94 |
| AbbVie | 1 | $86 |
| Sobi, Inc | 4 | $84 |
| Johnson & Johnson | 5 | $76 |
| Siemens Medical Solutions USA, Inc. | 3 | $72 |
| Jazz Pharmaceuticals Inc. | 3 | $70 |
| EMD Serono, Inc. | 2 | $41 |
| Amgen | 2 | $33 |
| Novartis | 1 | $32 |
| Taiho Oncology, Inc. | 1 | $27 |
| Blue Earth Diagnostics | 1 | $26 |
| GSK | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $21 |
| Boston Scientific | 1 | $20 |
| GE HealthCare | 1 | $20 |
| Bristol Myers Squibb | 1 | $16 |
| Incyte Corporation | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
| Ipsen Biopharmaceuticals, Inc | 1 | $13 |
| AVEO Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optune$23,211
- Oncology$9,272
- Optune Gio$160
- SIR-Spheres Microspheres$117
- IMFINZI$114
How this compares
$37,195 in reported general payments places this provider in the 95th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 40 | $412 |
| Dexamethasone | 65 | $407 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Richardson
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
- Chad TangHouston$183K
- Phuoc TranHouston$177K
- Hak ChoyDallas$119K
- Steven LinHouston$105K
- Benjamin SchrankHouston$100K
- Robert TimmermanDallas$77K
- Abhilasha PatelHouston$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.